- Home
- AUDC vs HRTX Comparison
AUDC vs HRTX Comparison
Compare AUDC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUDC | HRTX |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0M | 265.9M |
| IPO Year | 1999 | 1987 |
Fundamental Metrics
Financial Performance| Metric | AUDC | HRTX |
|---|---|---|
| Price | $7.64 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.50 | $4.50 |
| AVG Volume (30 Days) | 136.1K | ★ 1.5M |
| Earning Date | 02-03-2026 | 02-26-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $245,604,000.00 | $155,097,000.00 |
| Revenue This Year | $4.99 | $8.98 |
| Revenue Next Year | $1.45 | $11.57 |
| P/E Ratio | $24.06 | ★ N/A |
| Revenue Growth | 1.42 | ★ 12.60 |
| 52 Week Low | $7.22 | $1.00 |
| 52 Week High | $12.72 | $2.68 |
Technical Indicators
Market Signals| Indicator | AUDC | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 37.83 |
| Support Level | $7.22 | $1.19 |
| Resistance Level | $7.60 | $1.42 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 17.38 | 12.90 |
Price Performance
Historical ComparisonAbout AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.